mizolastine has been researched along with Chronic Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Chen, W; Chen, X; Li, F; Li, J; Li, Q; Liu, Z; Peng, C; Su, J; Yan, S; Zhang, J; Zhang, W; Zhu, W | 1 |
| Chen, M; Chen, W; Chen, X; Guo, A; He, Y; Li, J; Liu, Z; Su, J; Wen, S; Yan, S; Zeng, W; Zhang, C; Zhang, J; Zhao, Y; Zhou, H; Zhu, W | 1 |
| Blondin, P; Brostoff, J; Dunmore, C; Fitzharris, P; Theron, M | 1 |
| Dubertret, L; Murrieta Aguttes, M; Tonet, J | 1 |
| Giannetti, A; Leynadier, F; Lorette, G; Murrieta-Aguttes, M; Pereira, RS | 1 |
| Kontou-Fili, K | 1 |
| Aberer, W; Kränke, B | 1 |
3 trial(s) available for mizolastine and Chronic Disease
| Article | Year |
|---|---|
Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria.
Topics: Adult; Benzimidazoles; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Male; Middle Aged; Urticaria | 1996 |
Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
Topics: Adult; Analysis of Variance; Appendicitis; Benzimidazoles; Chronic Disease; Double-Blind Method; Electrocardiography; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Patient Dropouts; Pruritus; Severity of Illness Index; Treatment Outcome; Urticaria; Vasculitis | 1999 |
One-year treatment of chronic urticaria with mizolastine: efficacy and safety. URTOL study group.
Topics: Adult; Benzimidazoles; Chronic Disease; Female; Histamine H1 Antagonists; Humans; Male; Urticaria | 2000 |
4 other study(ies) available for mizolastine and Chronic Disease
| Article | Year |
|---|---|
C-reactive protein (CRP) rs3093059C predicts poor mizolastine response in chronic spontaneous urticaria patients with elevated serum CRP level.
Topics: Adolescent; Adult; Aged; Animals; Benzimidazoles; C-Reactive Protein; China; Chronic Disease; Chronic Urticaria; Female; Gene Expression; Genotype; HEK293 Cells; Histamine H1 Antagonists; Humans; Interleukin-6; Loratadine; Male; Middle Aged; Polymorphism, Single Nucleotide; Rats; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2019 |
Influence of component 5a receptor 1 (C5AR1) -1330T/G polymorphism on nonsedating H1-antihistamines therapy in Chinese patients with chronic spontaneous urticaria.
Topics: Adolescent; Adult; Aged; Asian People; Benzimidazoles; Case-Control Studies; China; Chronic Disease; Female; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Receptor, Anaphylatoxin C5a; Risk Factors; Treatment Outcome; Urticaria; Young Adult | 2014 |
Clinical advantages of dual activity in urticaria.
Topics: Acute Disease; Anti-Allergic Agents; Benzimidazoles; Chronic Disease; Clinical Trials as Topic; Cold Temperature; Histamine; Histamine H1 Antagonists; Humans; Leukotrienes; Lipoxygenase Inhibitors; Urticaria | 2000 |
One-year treatment of chronic urticaria with mizolastine: efficacy and safety. J Eur Acad Dermatol Venereol 2000; 14: 83-90.
Topics: Benzimidazoles; Chronic Disease; Histamine H1 Antagonists; Humans; Time Factors; Urticaria | 2001 |